{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:38:58Z","timestamp":1793299138669,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejps.2026.107474","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T16:54:51Z","timestamp":1771433691000},"page":"107474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Optimizing ibuprofen dosing: insights from in vivo and virtual pharmacokinetic trials"],"prefix":"10.1016","volume":"220","author":[{"given":"David","family":"Smr\u010dka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreela","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Dumicic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Ber\u00e1nek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejps.2026.107474_bib0001","first-page":"63","article-title":"Pharmacologic therapy for acute pain","volume":"104","author":"Amaechi","year":"2021","journal-title":"Am. Fam. Physician"},{"issue":"10","key":"10.1016\/j.ejps.2026.107474_bib0002","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.trac.2004.08.005","article-title":"Selected drugs in solid matrices: a review of environmental determination, occurrence and properties of principal substances","volume":"23","author":"Beausse","year":"2004","journal-title":"TrAC Trends Anal. Chem."},{"issue":"3","key":"10.1016\/j.ejps.2026.107474_bib0003","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/cpdd.297","article-title":"Analgesic efficacy of a new immediate-release\/extended-release formulation of Ibuprofen: results from single- and multiple-dose postsurgical dental pain studies","volume":"6","author":"Christensen","year":"2017","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/j.ejps.2026.107474_bib0004","unstructured":"Clinical guidelines - Diagnosis and treatment manual. Available from: https:\/\/medicalguidelines.msf.org\/en\/viewport\/CG\/english\/pain-16689104.html."},{"issue":"2","key":"10.1016\/j.ejps.2026.107474_bib0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00003088-199834020-00002","article-title":"Clinical pharmacokinetics of Ibuprofen","volume":"34","author":"Davies","year":"1998","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.ejps.2026.107474_bib0006","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s002280050258","article-title":"Comparison of the antinociception produced by two oral formulations of ibuprofen: ibuprofen effervescent vs ibuprofen tablets","volume":"52","author":"Hummel","year":"1997","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejps.2026.107474_bib0007","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s11095-024-03688-0","article-title":"The use of global sensitivity analysis to assess the oral absorption of weakly basic compounds: a case example of dipyridamole","volume":"41","author":"Kesharwani","year":"2024","journal-title":"Pharm. Res."},{"issue":"260","key":"10.1016\/j.ejps.2026.107474_bib0008","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/01621459.1952.10483441","article-title":"Use of ranks in one-criterion variance analysis","volume":"47","author":"Kruskal","year":"1952","journal-title":"J. Am. Stat. Assoc."},{"issue":"1","key":"10.1016\/j.ejps.2026.107474_bib0009","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/cpdd.288","article-title":"Single- and multiple-dose pharmacokinetics of immediate-release\/extended-release ibuprofen tablets","volume":"6","author":"Legg","year":"2017","journal-title":"Clin. Pharmacol. Drug Dev."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2026.107474_bib0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0378-5173(02)00645-2","article-title":"Effect of buffer media composition on the solubility and effective permeability coefficient of ibuprofen","volume":"253","author":"Levis","year":"2003","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejps.2026.107474_bib0011","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/0091270010389470","article-title":"Modeling the onset and offset of dental pain relief by ibuprofen","volume":"52","author":"Li","year":"2012","journal-title":"J. Clin. Pharmacol."},{"issue":"11","key":"10.1016\/j.ejps.2026.107474_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e21260","article-title":"Ultraviolet light spectroscopic characterization of ibuprofen acid aggregation in deionized water","volume":"9","author":"Marb\u00e1n","year":"2023","journal-title":"Heliyon."},{"issue":"2","key":"10.1016\/j.ejps.2026.107474_bib0013","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/FPC.0000000000000113","article-title":"PharmGKB summary: ibuprofen pathways","volume":"25","author":"Mazaleuskaya","year":"2015","journal-title":"Pharmacogenet. Genom."},{"key":"10.1016\/j.ejps.2026.107474_bib0014","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ijcp.12053","article-title":"Ibuprofen blood plasma levels and onset of analgesia","volume":"67","author":"Mehlisch","year":"2013","journal-title":"Int. J. Clin. Pr."},{"issue":"1","key":"10.1016\/j.ejps.2026.107474_bib0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pain.2013.08.013","article-title":"Faster, higher, stronger? Evidence for formulation and efficacy for ibuprofen in acute pain","volume":"155","author":"Moore","year":"2014","journal-title":"PAIN\u00ae"},{"issue":"3","key":"10.1016\/j.ejps.2026.107474_bib0016","first-page":"475","article-title":"Simulation of the in vivo exposure to ibuprofen based on in vitro dissolution profiles from solid dosage forms","volume":"62","author":"Popa","year":"2014","journal-title":"Farmacia"},{"key":"10.1016\/j.ejps.2026.107474_bib0017","unstructured":"Rainsford, K.D., Ibuprofen: a critical bibliographic review. 2003."},{"issue":"6","key":"10.1016\/j.ejps.2026.107474_bib0018","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10787-009-0016-x","article-title":"Ibuprofen: pharmacology, efficacy and safety","volume":"17","author":"Rainsford","year":"2009","journal-title":"Inflammopharmacology."},{"key":"10.1016\/j.ejps.2026.107474_bib0019","series-title":"Ibuprofen: pharmacology, Therapeutics and Side Effects","author":"Rainsford","year":"2013"},{"key":"10.1016\/j.ejps.2026.107474_bib0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ijcp.12055","article-title":"Ibuprofen: from invention to an OTC therapeutic mainstay","volume":"67","author":"Rainsford","year":"2013","journal-title":"Int. J. Clin. Pr."},{"issue":"4","key":"10.1016\/j.ejps.2026.107474_bib0021","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.2042-7158.1997.tb06809.x","article-title":"Ibuprofen and paracetamol: relative safety in non-prescription dosages","volume":"49","author":"Rainsford","year":"1997","journal-title":"J. Pharm. Pharmacol."},{"issue":"7","key":"10.1016\/j.ejps.2026.107474_bib0022","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/bdd.1800","article-title":"In silico prediction of drug dissolution and absorption with variation in intestinal pH for BCS class II weak acid drugs: ibuprofen and ketoprofen","volume":"33","author":"Tsume","year":"2012","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejps.2026.107474_bib0023","series-title":"ggplot2: Elegant Graphics FOR Data Analysis","first-page":"189","article-title":"Data analysis","author":"Wickham","year":"2016"},{"issue":"43","key":"10.1016\/j.ejps.2026.107474_bib0024","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the Tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J. Open. Source Softw."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726000485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726000485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T07:11:50Z","timestamp":1773472310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726000485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":24,"alternative-id":["S0928098726000485"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107474","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing ibuprofen dosing: insights from in vivo and virtual pharmacokinetic trials","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107474","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107474"}}